Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer-Reference-Cited by-同舟云学术

Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer

Published:2006-09-05 Issue:16 Volume:66 Page:1768-1778
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Isaacs John T.,Pili Roberto,Qian David Z.,Dalrymple Susan L.,Garrison Jason B.,Kyprianou Natasha,Björk Anders,Olsson Anders,Leanderson Tomas

Funder

The Johns Hopkins University School of Medicine and Active Biotech

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.20509/fullpdf

Reference28 articles.

1. The antitumor effects of the quinoline-3-carboxamide Linomide on Dunning R-3327 rat prostatic cancers;Ichikawa;Cancer Res,1992

2. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent Linomide;Vukanovic;Cancer Res,1995

3. Antiangiogenic treatment with Linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents;Joseph;Cancer Res,1996

4. Antiangiogenic effects of the quinoline-3-carboxamide Linomide;Vukanovic;Cancer Res,1993

5. Inhibition of tumor angiogenesis and the therapeutic ability of Linomide against rat prostatic cancers;Vukanovic;Prostate,1995

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models;The Prostate;2024-04-15

2. Identification of a shared gene signature and biological mechanism between diabetic foot ulcers and cutaneous lupus erythemnatosus by transcriptomic analysis;Frontiers in Physiology;2024-02-16

3. Novel effect of topical Roquinimex and its combination with Clobetasol on an imiquimod-induced model of psoriasis in mice;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-24

4. Novel Multi-Target Agents Based on the Privileged Structure of 4-Hydroxy-2-quinolinone;Molecules;2023-12-28

5. Third generation quinoline‐3‐carboxamide transcriptional disrupter of HDAC4, HIF‐1α, and MEF‐2 signaling for metastatic castration‐resistant prostate cancer;The Prostate;2023-08-09